1887

Journal of General Virology header logo

Volume 58, Issue 1

Effects of n-Butyrate on Epstein—Barr Virus-carrying Lymphoma Lines Free

Abstract

SUMMARY

n-Butyrate has been shown to induce Epstein—Barr virus (EBV) antigen synthesis in certain EBV-carrying lymphoma lines (Luka ., 1979). We have studied the effect of n-butyrate on two EBV-positive Burkitt lymphoma lines by immunofluorescence and electron microscopy. In the producer line P3HR-1, the drug induced not only early antigen (EA) and virus capsid antigen (VCA) synthesis, as shown before, but also increased the number of cells containing virus particles. The transition from VCA expression to the formation of virus particles was much more effective in treated cells than in EBV antigen-producing cells of the same line. The productive cycle was associated with the development of characteristic morphological changes. In the non-producer Raji cells, n-butyrate induced EA in only a minor fraction of the cells. There were, however, clear signs of differentiation in the direction of plasma cells. Two days after the addition of n-butyrate 80% of the Raji cells could be classified as plasmablasts. After 72 h, 20% of the cells appeared as typical plasma cells.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): EBV , n-butyrate effect , P3HR-1 and Raji cells
© Journal of General Virology 1982
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-58-1-163
1982-01-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/58/1/JV0580010163.html?itemId=/content/journal/jgv/10.1099/0022-1317-58-1-163&mimeType=html&fmt=ahah

References

  1. Andersson L. C., Jokinen M., Gahmberg C. G. 1979; Induction of erythroid differentiation in the human leukemia cell line K562. Nature, London 278:364–365
     [Google Scholar]
  2. Anisimova E., Tuckova E., Vonka V., Zavadova H. 1977; Ultrastructural changes induced by influenza viruses in permissive and nonpermissive cells. Virology 77:330–336
     [Google Scholar]
  3. Epstein M. A., Achong B. G. 1979; Morphology of the virus and of virus-induced cytopathological changes. In The Epstein-Barr Virus pp 23–37 Edited by Epstein M. A., Achong B. G. Heidelberg: Springer-Verlag;
     [Google Scholar]
  4. Ernberg I., Klein G. 1979; EB virus-induced antigens. In The Epstein-Barr Virus pp 39–60 Edited by Epstein M. A., Achong B. G. Heidelberg: Springer-Verlag;
     [Google Scholar]
  5. Ernberg I., Moar M. H. 1981; Induction of Epstein-Barr virus early antigen, viral capsid antigen and viral DNA synthesis by mitomycin C. Journal of General Virology 52:39–48
     [Google Scholar]
  6. Gerber P. 1972; Activation of Epstein-Barr virus by 5-bromodeoxyuridine in ‘virus-free’ human cells. Proceedings of the National Academy of Sciences of the United States of America 69:83–85
     [Google Scholar]
  7. Gergely L., Klein G., Ernberg I. 1971; Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by continued immunofluorescence and radioautography. Virology 45:22–29
     [Google Scholar]
  8. Hampar B., Derge J. G., Nonoyama M., Chang S. Y., Tagamets M. A., Showalter S. D. 1974; Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine. Virology 62:71–89
     [Google Scholar]
  9. Hinuma Y., Grace J. T. 1967; Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long term cultures. Proceedings of the Society for Experimental Biology and Medicine 124:107–111
     [Google Scholar]
  10. Huberman E., Callaham M. F. 1979; Induction of terminal differentiation in human promyelotic leukemia cells by tumor-promoting agents. Proceedings of the National Academy of Sciences of the United States of America 76:1293–1297
     [Google Scholar]
  11. Kalun B., Luka J., Klein G. 1979; Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate treated P3HR-1 cells. Journal of Virology 32:710–716
     [Google Scholar]
  12. Klein G., Dombos L., Gothoskar B. 1972; Sensitivity of Epstein-Barr virus (EBV) producer and nonproducer human lymphoblastoid cell lines to superinfection with EB-virus. International Journal of Cancer 10:44–57
     [Google Scholar]
  13. Leder A., Leder P. 1975; Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5:319–322
     [Google Scholar]
  14. Lotem J., Sacks L. 1979; Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proceedings of the National Academy of Sciences of the United States of America 76:5158–5162
     [Google Scholar]
  15. Luka J., Kallin B., Klein G. 1979; Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231
     [Google Scholar]
  16. Magrath I. T., Pizzo P. A., Novikovs L., Levine A. S. 1979; Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. Virology 97:477–481
     [Google Scholar]
  17. Miao R. M., Fieldsteel A. H., Fodge D. W. 1978; Opposing effects of tumour promoters on erythroid differentiation. Nature, London 274:271–272
     [Google Scholar]
  18. Mori R., Minamishima Y., Tasaki T., Oda H., Takade A. 1973; Hexagonal arrangements of filaments in herpes simplex virus type 2-infected cells. Japanese Journal of Microbiology 17:230–232
     [Google Scholar]
  19. Murphy F. A., Harrison A. K., Whitfield S. T. 1967; Intranuclear formation of filaments in herpesvirus hominis infection of mice. Archiv für die gesamte Virusforschung 21:463–468
     [Google Scholar]
  20. Nagasawa K., Mak T. W. 1980; Phorbol esters induce differentiation in human malignant T-lymphoblasts. Proceedings of the National Academy of Sciences of the United States of America 77:2964–2968
     [Google Scholar]
  21. Nilsson K. 1978; Established human lymphoid cell lines as models for B-lymphocyte differentiation. In Human Lymphocyte Differentiation: Its Application to Cancer pp 307–317 Edited by Serrou B., Rosenfeld C. Amsterdam: Elsevier/North-Holland Biomedical Press;
     [Google Scholar]
  22. Nonoyama M., Pagano J. S. 1972; Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infections. Journal of Virology 9:714–716
     [Google Scholar]
  23. Prasad K. N., Sinha P. K. 1976; Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro 12:125–132
     [Google Scholar]
  24. Pulvertaft R. J. V. 1965; A study of malignant tumors in Nigeria by short-term tissue culture. Journal of Clinical Pathology 18:261–273
     [Google Scholar]
  25. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
     [Google Scholar]
  26. Rovera G., O’brien T. G., Diamond L. 1979; Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science 204:868–870
     [Google Scholar]
  27. Saemundsen A. K., Kallin B., Klein G. 1980; Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology 107:557–561
     [Google Scholar]
  28. Steinitz M., Bakacs T., Klein G. 1978; Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes. International Journal of Cancer 22:251–257
     [Google Scholar]
  29. Totterman T. H., Nilsson K., Sundstrom C. 1980; Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature, London 288:176–178
     [Google Scholar]
  30. Tovey M. G., Lenoir G., Begon-lours J. 1978; Activation of latent Epstein-Barr virus by antibody to human IgM. Nature, London 276:270–272
     [Google Scholar]
  31. Trumper P. A., Epstein M. A., Giovanella B. C. 1976; Activation in vitro by BUdR of a productive EB virus infection in the epithelial cells of nasopharyngeal carcinoma. International Journal of Cancer 17:567–587
     [Google Scholar]
  32. Young S. K., Rowe N. H., Sanderlin K. C. 1977; Herpes simplex virus 1 and 2 in clinical infections: differences observed by electron microscopy. Journal of Infectious Diseases 135:486–489
     [Google Scholar]
  33. Zurhausen H., Bornkamm G. W., Schmidt R., Hecker E. 1979; Tumor initiators and promoters of the induction of Epstein-Barr virus. Proceedings of the National Academy of Sciences of the United States of America 76:782–785
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-58-1-163
Loading
Effects of n-Butyrate on Epstein—Barr Virus-carrying Lymphoma Lines
J. Gen. Virol. 58, 163 (1982); https://doi.org/10.1099/0022-1317-58-1-163
/content/journal/jgv/10.1099/0022-1317-58-1-163
/content/journal/jgv/10.1099/0022-1317-58-1-163
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error